Crossmark

High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-026-19133-y

Published Online: 2026-02-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rodriguez, Luke

Wu, Rongrong

Kassi, Anelia

Ishikawa, Takashi

Takabe, Kazuaki https://orcid.org/0000-0002-6435-4241
Funding

Funding for this research was provided by:

National Cancer Institute (P30-CA016056)

Clinical Center (R01CA250412)

Clinical Center (R01CA287731)

Clinical Center (R37CA248018)

US Department of Defense BCRP (HT9425-24-1-0762)

US Department of Defense BCRP (W81XWH-19-1-0674)
License Information

Text and Data Mining valid from 2026-02-19

Version of Record valid from 2026-02-19
More Information

Article History

Received: 28 October 2025

Accepted: 9 January 2026

First Online: 19 February 2026

Disclosure

: There are no conflicts of interest.

Document is current

Any future updates will be listed below